Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine IV vs TAP Block for Post-operative Pain
NCT05231941Completed
- Sponsor
- Aga Khan University Hospital
- Start
- Feb 2022
- Primary completion
- Oct 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Aga Khan University Hospital. Primary endpoint: Visual Analog Scale at 24 hours. Started Feb 2022; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05231941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05231941.